Via College Research Recognition Day features 'father of microbial genetics'

August 26, 2005

Blacksburg, Va. -- Nobel Laureate Joshua Lederberg will be the keynote speaker at the Second Annual Via Virginia College of Osteopathic Medicine (VCOM) Research Recognition Day on Oct. 5, 2005. Lederberg will speak on "The Scientific Basis for FDA's Regulatory Balance between Assurance of Safety versus the Innovation to keep up with Disease: No drug can ever be proven perfectly safe for every member of the 'prescribee' population."

Lederberg was awarded the Nobel Prize in medicine and physiology in 1958 at age 33 "for his discoveries concerning genetic recombination and the organization of the genetic material of bacteria." He has also been actively involved in artificial intelligence research in computer science and has been a consultant on health-related matters for government and the international community. From 1978 to 1990, he served as president of Rockefeller University, where he continues his research activities.

The second annual Via Research Recognition Day will feature research by VCOM and Virginia Tech faculty members in three areas -- aging and neurological research, bone and joint research, and cancer and immunology.

Other speakers will be Peter Hotez, professor and chair of microbiology and tropical medicine at George Washington University, and Marguerite Lederberg, M.D., clinical professor of psychiatry at Memorial Sloan Kettering Cancer Center in New York.

Holtez will speak on "The Neglected Tropical Disease: The Ancient Afflictions of Stigma and Poverty and the Prospects for their Control and Elimination." He heads the Section on Helminths for the Disease Control Priorities 2 Initiative of the World Health Organization, World Bank, and Fogarty International Center, and is co-chair of the Scientific Advisory Council of the Sabin Vaccine Institute. He is the author of the books, Parasitic Diseases (Apple Tree Press) and Krugman's Infectious Diseases of Children (Mosby).

Marguerite Lederberg will present on "Family Decision-makers: Their underestimated psychological and ethical burden." She specializes in psychological and psychiatric problems of patients with cancer and their families and ethical issues in the care of patients with cancer.

To register, contact Varelos at 540-231-3150, or email kvarelos@ vcom.vt.edu. Pre registration by Sept. 5 is free. On-site registration the day of the event is $50. Registration includes admission to all sessions, continental breakfast, beverages and lunch.
-end-
The Virginia College of Osteopathic Medicine is accredited by the American Osteopathic Association (AOA) to provide continuing medical education for physicians. This program is eligible for eight hours of category one credit, AOA.

For more information about the conference, contact Hara Misra, associate dean for biomedical academic and research affairs, at misra@vt.edu or 540-231-3693. Learn more about the college at http://www.vcom.vt.edu. The college is located at 2265 Kraft Dr. in Blacksburg.

For information on accommodations and directions, see the PDF file linked from http://www.vcom.vt.edu/general/news/.

Virginia Tech

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.